PMMR/MSS LOCALLY ADVANCED RECTAL CANCER
Clinical trials for PMMR/MSS LOCALLY ADVANCED RECTAL CANCER explained in plain language.
Never miss a new study
Get alerted when new PMMR/MSS LOCALLY ADVANCED RECTAL CANCER trials appear
Sign up with your email to follow new studies for PMMR/MSS LOCALLY ADVANCED RECTAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to outsmart 'Cold' rectal tumors
Disease control Recruiting nowThis Phase II trial tests whether adding a dual immunotherapy drug (iparomlimab/tuvonralimab) to standard chemoradiotherapy can improve outcomes for patients with locally advanced rectal cancer that has a specific genetic profile (pMMR/MSS), which usually does not respond to immu…
Matched conditions: PMMR/MSS LOCALLY ADVANCED RECTAL CANCER
Phase: PHASE2 • Sponsor: Shandong Cancer Hospital and Institute • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Immunotherapy combo shows promise in Hard-to-Treat rectal cancer
Disease control Recruiting nowThis phase 2 trial tests whether adding an immunotherapy drug (PD-1 antibody) and a blood vessel blocker (bevacizumab) to standard short-course radiotherapy and chemotherapy can improve outcomes for people with a common type of locally advanced rectal cancer (pMMR/MSS). About 86 …
Matched conditions: PMMR/MSS LOCALLY ADVANCED RECTAL CANCER
Phase: PHASE2 • Sponsor: Dechang Diao • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC